<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Affinity Peptides</title>
    <link>http://localhost:1313/</link>
    <description>Recent content on Affinity Peptides</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 21 Jan 2026 14:58:46 -0600</lastBuildDate>
    <atom:link href="http://localhost:1313/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Tb 500</title>
      <link>http://localhost:1313/peptides/tb-500/</link>
      <pubDate>Wed, 21 Jan 2026 14:58:46 -0600</pubDate>
      <guid>http://localhost:1313/peptides/tb-500/</guid>
      <description></description>
    </item>
    <item>
      <title>Mots C</title>
      <link>http://localhost:1313/peptides/mots-c/</link>
      <pubDate>Wed, 21 Jan 2026 14:58:41 -0600</pubDate>
      <guid>http://localhost:1313/peptides/mots-c/</guid>
      <description></description>
    </item>
    <item>
      <title>Bpc 157</title>
      <link>http://localhost:1313/peptides/bpc-157/</link>
      <pubDate>Wed, 21 Jan 2026 14:58:37 -0600</pubDate>
      <guid>http://localhost:1313/peptides/bpc-157/</guid>
      <description></description>
    </item>
    <item>
      <title>Ghk Cu</title>
      <link>http://localhost:1313/peptides/ghk-cu/</link>
      <pubDate>Wed, 21 Jan 2026 14:58:32 -0600</pubDate>
      <guid>http://localhost:1313/peptides/ghk-cu/</guid>
      <description></description>
    </item>
    <item>
      <title>About Affinity Peptides</title>
      <link>http://localhost:1313/about/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/about/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Affinity Peptides&lt;/strong&gt; is an independent, research-focused platform dedicated to the scientific exploration of peptide biology, metabolic health, and regenerative medicine.&lt;/p&gt;&#xA;&lt;p&gt;The purpose of this site is to curate, organize, and interpret peer-reviewed biomedical research in a way that is accessible, transparent, and evidence-based.&lt;/p&gt;&#xA;&lt;p&gt;We focus on:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Peptide signaling and receptor biology&lt;/li&gt;&#xA;&lt;li&gt;Metabolic regulation and obesity research&lt;/li&gt;&#xA;&lt;li&gt;Growth hormone and tissue regeneration&lt;/li&gt;&#xA;&lt;li&gt;Inflammatory and immune modulation&lt;/li&gt;&#xA;&lt;li&gt;Emerging therapeutic peptides&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;All information published on this platform is derived from:&lt;/p&gt;</description>
    </item>
    <item>
      <title>Contact</title>
      <link>http://localhost:1313/contact/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/contact/</guid>
      <description>&lt;p&gt;For research inquiries, collaborations, or general questions, you may contact Affinity Peptides through the following channels:&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Email:&lt;/strong&gt;&lt;br&gt;&#xA;&lt;a href=&#34;mailto:contact@affinitypeptides.com&#34;&gt;contact@affinitypeptides.com&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;WhatsApp:&lt;/strong&gt;&lt;br&gt;&#xA;&lt;a href=&#34;https://wa.me/message/PRBWJ5GAFOTFK1&#34;&gt;Click here to message&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Social Media:&lt;/strong&gt;&lt;br&gt;&#xA;Instagram&lt;br&gt;&#xA;Facebook&lt;br&gt;&#xA;Telegram&lt;/p&gt;&#xA;&lt;p&gt;This platform does not provide medical advice. All inquiries should be related to scientific or educational topics.&lt;/p&gt;&#xA;&lt;hr&gt;</description>
    </item>
    <item>
      <title>Retatrutide</title>
      <link>http://localhost:1313/peptides/retatrutide/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/peptides/retatrutide/</guid>
      <description>&lt;h2 id=&#34;overview&#34;&gt;Overview&lt;/h2&gt;&#xA;&lt;p&gt;Retatrutide is an investigational triple-agonist peptide designed to target three key metabolic hormone receptors involved in weight regulation and glucose control:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;GLP-1 (glucagon-like peptide-1)&lt;/li&gt;&#xA;&lt;li&gt;GIP (glucose-dependent insulinotropic polypeptide)&lt;/li&gt;&#xA;&lt;li&gt;Glucagon receptor&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;This multi-receptor approach is intended to improve metabolic flexibility, enhance fat loss, and preserve lean mass more effectively than single-pathway therapies.&lt;/p&gt;&#xA;&lt;hr&gt;&#xA;&lt;h2 id=&#34;mechanism-of-action&#34;&gt;Mechanism of Action&lt;/h2&gt;&#xA;&lt;p&gt;Retatrutide activates:&lt;/p&gt;&#xA;&lt;table&gt;&#xA;  &lt;thead&gt;&#xA;      &lt;tr&gt;&#xA;          &lt;th&gt;Receptor&lt;/th&gt;&#xA;          &lt;th&gt;Function&lt;/th&gt;&#xA;      &lt;/tr&gt;&#xA;  &lt;/thead&gt;&#xA;  &lt;tbody&gt;&#xA;      &lt;tr&gt;&#xA;          &lt;td&gt;GLP-1&lt;/td&gt;&#xA;          &lt;td&gt;Reduces appetite, slows gastric emptying, increases insulin secretion&lt;/td&gt;&#xA;      &lt;/tr&gt;&#xA;      &lt;tr&gt;&#xA;          &lt;td&gt;GIP&lt;/td&gt;&#xA;          &lt;td&gt;Enhances insulin response and nutrient partitioning&lt;/td&gt;&#xA;      &lt;/tr&gt;&#xA;      &lt;tr&gt;&#xA;          &lt;td&gt;Glucagon&lt;/td&gt;&#xA;          &lt;td&gt;Increases energy expenditure and fat oxidation&lt;/td&gt;&#xA;      &lt;/tr&gt;&#xA;  &lt;/tbody&gt;&#xA;&lt;/table&gt;&#xA;&lt;p&gt;By stimulating all three pathways, Retatrutide produces a synergistic metabolic effect that promotes weight loss while supporting glycemic control.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Safety, Ethics, and Research Use</title>
      <link>http://localhost:1313/safety/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/safety/</guid>
      <description>&lt;p&gt;Affinity Peptides exists as a &lt;strong&gt;scientific information platform&lt;/strong&gt; only.&lt;/p&gt;&#xA;&lt;p&gt;We do not:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Provide medical advice&lt;/li&gt;&#xA;&lt;li&gt;Diagnose or treat any condition&lt;/li&gt;&#xA;&lt;li&gt;Prescribe medications&lt;/li&gt;&#xA;&lt;li&gt;Sell pharmaceutical products&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;All information presented on this website is intended strictly for &lt;strong&gt;educational and research purposes&lt;/strong&gt;.&lt;/p&gt;&#xA;&lt;p&gt;Peptides discussed on this site are:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Investigational compounds&lt;/li&gt;&#xA;&lt;li&gt;Research chemicals&lt;/li&gt;&#xA;&lt;li&gt;Studied in laboratory and clinical research settings&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;Any human use of peptides must be supervised by a licensed medical professional.&lt;/p&gt;&#xA;&lt;p&gt;Readers are responsible for verifying information and consulting qualified healthcare providers before making health decisions.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Scientific Sources</title>
      <link>http://localhost:1313/sources/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/sources/</guid>
      <description>&lt;p&gt;All research on Affinity Peptides is based on primary scientific literature.&lt;/p&gt;&#xA;&lt;p&gt;Major sources include:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;PubMed&lt;/li&gt;&#xA;&lt;li&gt;National Institutes of Health (NIH)&lt;/li&gt;&#xA;&lt;li&gt;New England Journal of Medicine&lt;/li&gt;&#xA;&lt;li&gt;Nature&lt;/li&gt;&#xA;&lt;li&gt;Cell&lt;/li&gt;&#xA;&lt;li&gt;Science&lt;/li&gt;&#xA;&lt;li&gt;FDA clinical trial databases&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;Individual research articles are cited directly on each peptide and study page.&lt;/p&gt;&#xA;&lt;p&gt;This platform prioritizes:&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Peer-reviewed evidence&lt;/li&gt;&#xA;&lt;li&gt;Human clinical trials when available&lt;/li&gt;&#xA;&lt;li&gt;Mechanistic biological research&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;No information is taken from blogs, forums, or non-scientific media.&lt;/p&gt;&#xA;&lt;hr&gt;&#xA;&lt;p&gt;&lt;em&gt;We are committed to accurate sourcing and scientific integrity.&lt;/em&gt;&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
